Copyright
©The Author(s) 2016.
World J Radiol. Aug 28, 2016; 8(8): 735-742
Published online Aug 28, 2016. doi: 10.4329/wjr.v8.i8.735
Published online Aug 28, 2016. doi: 10.4329/wjr.v8.i8.735
HT (n = 31) | VMAT (n = 42) | |
Age | 50 | 52 |
Laterality | ||
Right | 56.8% | 50% |
Left | 43.2% | 50% |
Quadrant | ||
IQ | 70.2% | 40% |
Outer quadrants | 29.8% | 60% |
Size (mm) | 25.4 | 25 |
N stage | ||
N0 | 37.8% | 21% |
N1 | 48.6% | 42% |
N2 | 13.5% | 23% |
N3 | 0% | 14% |
Grade | ||
1 | 2.7% | 7% |
2 | 45.9% | 31% |
3 | 51.4% | 62% |
LVI | ||
- | 59.5% | 77% |
+ | 40.5% | 23% |
Hormone receptors | ||
RH+ | 76% | 77% |
RH- | 24% | 29% |
Triple negative | 18.9% | 24% |
HER2 | ||
+ | 16.2% | 14% |
- | 83.8% | 86% |
Tobacco | 16.2% | 20.9% |
BMI (kg/m2) | 25.8 | 25.9 |
Chemotherapy | ||
Neoadjuvant | 30% | 29% |
Adjuvant | 49% | 64% |
Concurrent | 4% | 0% |
Irradiation N | ||
SN | 100% | 98% |
IMC | 100% | 100% |
Axillary | 16.2% | 19% |
- Citation: Lauche O, Kirova YM, Fenoglietto P, Costa E, Lemanski C, Bourgier C, Riou O, Tiberi D, Campana F, Fourquet A, Azria D. Helical tomotherapy and volumetric modulated arc therapy: New therapeutic arms in the breast cancer radiotherapy. World J Radiol 2016; 8(8): 735-742
- URL: https://www.wjgnet.com/1949-8470/full/v8/i8/735.htm
- DOI: https://dx.doi.org/10.4329/wjr.v8.i8.735